Back to search
Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3 trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3 trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This phase II Pediatric MATCH trial studies how well erdafitinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders wi…
This is a multi-center, open label, non-randomized Phase 1 study, to be conducted in two parts, Part A, and Part B. Part A in solid tumors included the dose esc…
The study will determine the maximum tolerated dose and thus the recommended phase II dose and schedule of the compound and characterize the safety.